Invesco Nasdaq Technology ETF will be suspended from market open on 2026-10-21 and will resume trading at 10:30 that day. Redemptions will continue to be processed during the suspension.

China's National Medical Products Administration (NMPA) on Oct. 19 met to advance its AI + drug regulation agenda, directing regulators to set rules, steady expectations, enhance services and build an AI-enabled ecosystem to support pharmaceutical innovation. The NMPA said it will draft special plans to back priority tracks, shift review services upstream toward innovators, and create an innovation-encouraging yet prudently risk-aware regulatory environment; it called for using AI to improve drug-safety governance—making reviews smarter, inspections and enforcement more precise, risk controls more sensitive and coordinated supervision more efficient—and for establishing a full-lifecycle, continuously iterated AI application management mechanism, centralizing resources, training specialist talent, promoting technology-for-good and safeguarding AI security standards.

以色列總理內塔尼亞胡：有跡象表明，伊朗及其代理人希望在選舉前挑戰以色列。